Early Prostate Cancer Antigen 2 (EPCA2) ELISA Kit for Human

Principle of the Assay||This assay employs the quantitative sandwich enzyme immunoassay technique. Antibody specific for EPCA2 has been pre-coated onto a microplate. Standards and samples are pipetted into the wells with a Horseradish Peroxidase (HRP) conjugated antibody specific for EPCA2. Following a wash to remove any unbound reagent, a substrate solution is added to the wells and color develops in proportion to the amount of EPCA2 bound in the initial step. The color development is stopped and the intensity of the color is measured.

Small volumes of EPCA2 elisa kit vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS706667 is a ready-to-use microwell, strip plate ELISA (enzyme-linked immunosorbent assay) Kit for analyzing the presence of the early prostate cancer antigen 2 (EPCA2) ELISA Kit target analytes in biological samples. The concentration gradients of the kit standards or positive controls render a theoretical kit detection range in biological research samples containing EPCA2. The ELISA analytical biochemical technique of the MBS706667 kit is based on EPCA2 antibody-EPCA2 antigen interactions (immunosorbency) and an HRP colorimetric detection system to detect EPCA2 antigen targets in samples. The ELISA Kit is designed to detect native, not recombinant, EPCA2. Appropriate sample types may include undiluted body fluids and/or tissue homogenates, secretions. Quality control assays assessing reproducibility identified the intra-assay CV (%) and inter-assay CV(%).